Cargando…

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra low density cancer epitopes

Detalles Bibliográficos
Autores principales:	Mathias, Melissa D., Sockolosky, Jonathan T., Chang, Aaron Y., Tan, Kay See, Liu, Cheng, Garcia, K. Christopher, Scheinberg, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628131/ https://www.ncbi.nlm.nih.gov/pubmed/28745331 http://dx.doi.org/10.1038/leu.2017.223

Ejemplares similares

A TCR mimic monoclonal antibody for the HPV-16 E7-epitope p11-19/HLA-A*02:01 complex
por: Dao, Tao, et al.
Publicado: (2022)

Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
por: Dao, Tao, et al.
Publicado: (2019)

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021)

TCR-mimic bispecific antibodies to target the HIV-1 reservoir
por: Sengupta, Srona, et al.
Publicado: (2022)

Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
por: Dheilly, Elie, et al.
Publicado: (2018)

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
por: Dheilly, Elie, et al.
Publicado: (2017)

Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

A TCR mimic monoclonal antibody reactive with the “public” phospho-neoantigen pIRS2/HLA-A*02:01 complex
por: Dao, Tao, et al.
Publicado: (2022)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors
por: Liu, Xiaojuan, et al.
Publicado: (2015)

CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils
por: Haj-Yehia, Elias, et al.
Publicado: (2023)

CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE
por: Wang, Huan, et al.
Publicado: (2021)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
por: Yang, Yun, et al.
Publicado: (2023)

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
por: Tahk, Siret, et al.
Publicado: (2021)

CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
por: Xu, Ji-Feng, et al.
Publicado: (2015)

Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
por: Feng, Chen, et al.
Publicado: (2023)

Identification of Human Norovirus GII.3 Blockade Antibody Epitopes
por: Yi, Yufang, et al.
Publicado: (2021)

Identification of a GII.6 norovirus blockade antibody epitope
por: Huo, Yuqi, et al.
Publicado: (2023)

Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2018)

2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes
por: Kolawole, Elizabeth M., et al.
Publicado: (2018)

Broad TCR Repertoire And Diverse Structural Solutions To Recognition Of An Immunodominant CD8 T Cell Epitope
por: Song, InYoung, et al.
Publicado: (2017)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Chen, Shih-Hsun, et al.
Publicado: (2021)

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment
por: Wang, Rongjuan, et al.
Publicado: (2023)

Blockade of CD47 increases survival of mice exposed to lethal total body irradiation
por: Soto-Pantoja, David R., et al.
Publicado: (2013)

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
por: Candas-Green, Demet, et al.
Publicado: (2020)

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
por: Nishiga, Yoko, et al.
Publicado: (2022)

CD47 blockade ameliorates autoimmune vasculitis via efferocytosis of neutrophil extracellular traps
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Rapid TCR:Epitope Ranker (RAPTER): a primary human T cell reactivity screening assay pairing epitope and TCR at single cell resolution
por: Deering, Raquel P., et al.
Publicado: (2023)

Binding of TCR Multimers and a TCR-Like Antibody with Distinct Fine-Specificities Is Dependent on the Surface Density of HLA Complexes
por: Low, Jianrong L., et al.
Publicado: (2012)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies
por: Sim, Adrian Chong Nyi, et al.
Publicado: (2013)

Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
por: Park, Ha-Ram, et al.
Publicado: (2022)

Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma
por: Gao, Xingxing, et al.
Publicado: (2022)

CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer
por: Lau, Asa P. Y., et al.
Publicado: (2023)

Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01
por: Chikaev, Anton N., et al.
Publicado: (2015)

SIRPα - CD47 axis regulates dendritic cell-T cell interactions and TCR activation during T cell priming in spleen
por: Autio, Anu, et al.
Publicado: (2022)

Height, but not binding epitope, affects the potency of synthetic TCR agonists
por: Wilhelm, Kiera B., et al.
Publicado: (2021)

Height, but not binding epitope, affects the potency of synthetic TCR agonists
por: Wilhelm, Kiera B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84oe4n0qfr5d46g66h82babent